Skip to content

Country

Lauda Recirculating Chiller Bath with E100 Controller

by Lauda
Availability:
2 in stock, ready to be shipped
SKU 10589
Save 31% Save 31%
Original price $1,100.00
Original price $1,100.00 - Original price $1,100.00
Original price $1,100.00
Current price $760.00
$760.00 - $760.00
Current price $760.00

The Lauda Proline RE 106 with the E 100 Controller is a high-precision refrigerated and heating circulator designed for professional laboratory use. It is part of the Proline series, which is known for its modular design and exceptional temperature stability, making it ideal for everything from standard sample tempering to complex external temperature control.

The RE 106 is a robust cooling unit that, when paired with the E 100 "Economy" controller, provides a balanced mix of performance and user-friendly operation.

  • Working Temperature Range: -20°C to +150°C.

  • Temperature Stability: Maintains a high precision of ±0.02°C, critical for sensitive analytical chemistry or biological assays.

  • Cooling Capacity: Provides 0.16 kW of cooling at 20°C, dropping to approximately 0.05 kW at -20°C.

  • Heating Capacity: Equipped with a 1.3 kW heater (at 230V) or 1.0 kW (at 115V) for rapid temperature recovery.

E 100 Controller Features

The E 100 is the digital interface that governs the bath's operations. While labeled "Economy," it still offers professional-grade features:

  • Digital Display: Features a clear LED display showing the actual and setpoint temperatures.

  • Safety: Includes an adjustable over-temperature protector and a low-level liquid alarm to prevent motor and heater damage.

  • Pump Control: Controls a powerful pressure pump with a flow rate of 17 L/min and a maximum pressure of 0.4 bar, suitable for circulating fluid through external refractometers, viscometers, or jacketed reactors.

Used; excellent condition.

Please note that Life Sciences Trading is not a factory-authorized distributor of the products listed in this store. The items have been acquired as surplus from leading life sciences companies.